Search research articles
Contact Us
Filters
Showing results (11-20 of 21) with videos related to
Page
of 3
Sort By:
Therapeutic Advances in Medical Oncology
|
December 18, 2023
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab
Alessandro Passardi, Irene Azzali, Alessandro Bittoni, et al.
Cancers
|
July 27, 2024
PD-L1 Expression in Paired Samples of Rectal Cancer
Mina Coussement, Roberta Fazio, Alessandro Audisio, et al.
JMIR Research Protocols
|
April 21, 2023
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study
Joaquim Reis, Luzia Travado, Alexander Scherrer, et al.
JCO Precision Oncology
|
September 1, 2023
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
Milena Urbini, Giorgia Marisi, Irene Azzali, et al.
Cancers
|
October 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study
Carlo Signorelli, Michele Basso, Maria Alessandra Calegari, et al.
Cancers
|
June 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study
Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Oncology
|
August 15, 2025
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy
Francesco Vitiello, Caterina Vivaldi, Mario Domenico Rizzato, et al.
International Journal of Cancer
|
July 11, 2025
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population
Federica Lo Prinzi, Francesca Salani, Silvia Camera, et al.
Targeted Oncology
|
February 27, 2026
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
Silvia Camera, Lorenzo Fornaro, Margherita Rimini, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
Page
of 3
Search research articles
Search
Showing results (11-20 of 21) with videos related to
Sort By:
Page
of 3
Therapeutic Advances in Medical Oncology
|
December 18, 2023
Inflammatory indices as prognostic markers in metastatic colorectal cancer patients treated with chemotherapy plus Bevacizumab
Alessandro Passardi, Irene Azzali, Alessandro Bittoni, et al.
Cancers
|
July 27, 2024
PD-L1 Expression in Paired Samples of Rectal Cancer
Mina Coussement, Roberta Fazio, Alessandro Audisio, et al.
JMIR Research Protocols
|
April 21, 2023
Digital Guardian Angel Supported by an Artificial Intelligence System to Improve Quality of Life, Well-being, and Health Outcomes of Patients With Cancer (ONCORELIEF): Protocol for a Single Arm Prospective Multicenter Pilot Study
Joaquim Reis, Luzia Travado, Alexander Scherrer, et al.
JCO Precision Oncology
|
September 1, 2023
Dynamic Monitoring of Circulating Tumor DNA in Patients With Metastatic Colorectal Cancer
Milena Urbini, Giorgia Marisi, Irene Azzali, et al.
Cancers
|
October 29, 2025
Real-World Evidence of Regorafenib Dose Escalation Versus Fixed Dosing in Refractory Metastatic Colorectal Cancer: Results from the ReTrITA Study
Carlo Signorelli, Michele Basso, Maria Alessandra Calegari, et al.
Cancers
|
June 26, 2025
Redefining the Use of Regorafenib and Trifluridine/Tipiracil Without Bevacizumab in Refractory Metastatic Colorectal Cancer: Findings from the ReTrITA Study
Carlo Signorelli, Maria Alessandra Calegari, Annunziato Anghelone, et al.
Oncology
|
August 15, 2025
Impact of antibiotic therapy in patients with cholangiocarcinoma treated with chemoimmunotherapy
Francesco Vitiello, Caterina Vivaldi, Mario Domenico Rizzato, et al.
International Journal of Cancer
|
July 11, 2025
Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real-life worldwide population
Federica Lo Prinzi, Francesca Salani, Silvia Camera, et al.
Targeted Oncology
|
February 27, 2026
Prognostic Impact of Metastatic Sites in Patients with Biliary Tract Cancer Treated with Cisplatin, Gemcitabine, and Durvalumab
Silvia Camera, Lorenzo Fornaro, Margherita Rimini, et al.
JAMA Oncology
|
July 10, 2025
Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer
Alessandro Audisio, Chiara Gallio, Vaneja Velenik, et al.
Page
of 3